CAPR started moving up. DMD P3 trial starting this month FDA will give AA in the middle of P3 trial most likely $100 pps upon AA this year imo Exosome platform is worth billion dollars as well This is the most undervalued and safe bio play in recession period
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.